Cutler Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.93M | Sell |
163,108
-9
| -0% | -$235 | 0.37% | 60 |
|
|
2026
Q1 | $4.58M | Sell |
163,117
-2,152
| -1% | -$57.3K | 0.47% | 56 |
|
|
2025
Q4 | $4.12M | Sell |
165,269
-4,135
| -2% | -$104K | 0.43% | 56 |
|
|
2025
Q3 | $4.32M | Sell |
169,404
-3,345
| -2% | -$82.6K | 0.45% | 57 |
|
|
2025
Q2 | $4.19M | Sell |
172,749
-1,493
| -0.9% | -$34.8K | 0.47% | 57 |
|
|
2025
Q1 | $4.42M | Sell |
174,242
-2,434
| -1% | -$63.7K | 0.53% | 55 |
|
|
2024
Q4 | $4.69M | Buy |
+176,676
| New | +$4.79M | 0.58% | 51 |
|
|
2023
Q2 | – | Sell |
-5,406
| Closed | -$221K | – | 129 |
|
|
2023
Q1 | $221K | Sell |
5,406
-207
| -4% | -$8.94K | 0.03% | 125 |
|
|
2022
Q4 | $288K | Sell |
5,613
-168
| -3% | -$8.05K | 0.04% | 112 |
|
|
2022
Q3 | $253K | Sell |
5,781
-300
| -5% | -$14.6K | 0.04% | 111 |
|
|
2022
Q2 | $319K | Hold |
6,081
| – | – | 0.05% | 107 |
|
|
2022
Q1 | $315K | Buy |
+6,081
| New | +$316K | 0.04% | 115 |
|
|
2018
Q2 | – | Sell |
-7,938
| Closed | -$267K | – | 100 |
|
|
2018
Q1 | $267K | Hold |
7,938
| – | – | 0.05% | 77 |
|
|
2017
Q4 | $273K | Hold |
7,938
| – | – | 0.05% | 80 |
|
|
2017
Q3 | $269K | Hold |
7,938
| – | – | 0.06% | 70 |
|
|
2017
Q2 | $253K | Sell |
7,938
-123
| -2% | -$3.88K | 0.06% | 68 |
|
|
2017
Q1 | $262K | Hold |
8,061
| – | – | 0.06% | 67 |
|
|
2016
Q4 | $248K | Sell |
8,061
-11
| -0.1% | -$336 | 0.06% | 65 |
|
|
2016
Q3 | $259K | Sell |
8,072
-15
| -0.2% | -$502 | 0.07% | 65 |
|
|
2016
Q2 | $270K | Hold |
8,087
| – | – | 0.08% | 66 |
|
|
2016
Q1 | $227K | Hold |
8,087
| – | – | 0.07% | 69 |
|
|
2015
Q4 | $248K | Sell |
8,087
-27
| -0.3% | -$849 | 0.08% | 58 |
|
|
2015
Q3 | $242K | Hold |
8,114
| – | – | 0.09% | 58 |
|
|
2015
Q2 | $258K | Hold |
8,114
| – | – | 0.08% | 59 |
|
|
2015
Q1 | $268K | Hold |
8,114
| – | – | 0.09% | 59 |
|
|
2014
Q4 | $240K | Hold |
8,114
| – | – | 0.08% | 61 |
|
|
2014
Q3 | $228K | Sell |
8,114
-4,152
| -34% | -$117K | 0.08% | 56 |
|
|
2014
Q2 | $345K | Hold |
12,266
| – | – | 0.12% | 54 |
|
|
2014
Q1 | $374K | Hold |
12,266
| – | – | 0.13% | 53 |
|
|
2013
Q4 | $356K | Hold |
12,266
| – | – | 0.13% | 55 |
|
|
2013
Q3 | $334K | Hold |
12,266
| – | – | 0.13% | 54 |
|
|
2013
Q2 | $326K | Buy |
+12,266
| New | +$339K | 0.13% | 52 |
|
Other funds holding PFE
Cutler Investment Counsel's PFE Position: Q2 2026 in Review
Cutler Investment Counsel reduced its Pfizer (PFE) stake by 0.01% in Q2 2026, selling an estimated $235 and leaving 163,108 shares worth $3.93M. The position accounts for 0.37% of the portfolio, ranked #60.
Cutler Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 32 quarters since. The position peaked at $4.69M in Q4 2024. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Cutler Investment Counsel held 163,108 shares of Pfizer worth $3.93M as of Q2 2026.
- Cutler Investment Counsel sold 9 Pfizer shares in Q2 2026, an estimated $235.
- Pfizer made up 0.37% of Cutler Investment Counsel's portfolio in Q2 2026, its #60 holding.
- Cutler Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 32 quarters since.
- Cutler Investment Counsel's Pfizer position peaked at $4.69M in Q4 2024.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Cutler Investment Counsel's 13F filing for Q2 2026, filed 14 Jul 2026.